Publications

Duffy N, Koirala A, Williams PC. Epidemiology and outcomes of culture-proven neonatal meningitis in Australian tertiary hospitals: a multicenter retrospective cohort study. Pediatric Infectious Disease Journal 2026;45:e193-e195. doi: 10.1097/INF.0000000000005131 (Epub). [Full text]

Koirala A, Prasad SA, Tjiam MC, Britton PN, Tedja C, Downes M, Skowno J, Wadia UD, Blyth CC, Crawford NW, Marshall HS, Clark JE, Francis JR, Carr JP, Bartlett A, McMullan BJ, Carey E, Chung S, Davidson A, von Ungern-Sternberg BS, Archer PL, Burgoyne LL, Waugh EB, Ong MM, Tansil S, Thornton RB, McMinn A, Hunter G, D'Angelo N, Finucane C, Francis LA, Dougherty S, Naing Z, Wood N, Richmond P, Macartney K. SARS-CoV-2 ancestral and omicron variant immunity in Australian children in 2023, a seroprevalence study. Vaccine 2026;85:128705. doi: 10.1016/j.vaccine.2026.128705 . [Abstract]

Christou-Ergos M, Sabahelzain MM, Steffens M, Kaufman J, Bolsewicz KT, Danchin M, Leask J. Tracking the behavioural and social drivers of adult influenza vaccination: insights from Australia's first serial survey. Australia and New Zealand Journal of Public Health 2026:100324. doi: 10.1016/j.anzjph.2026.100324 . [Full text]

Fox A, Alafaci A, Carolan L, Burrell R, Sánchez-Ovando S, Hadiprodjo AJ, McMinn A, Macartney K, León AN, Ward AB, Wheatley A, Sullivan SG, Crawford NW, Britton PN, Subbarao K. Influenza vaccine responses differ between young children previously exposed to influenza antigens via infection versus vaccination. Communications Medicine 2026. doi: 10.1038/s43856-026-01610-w . [Full text]

Fathima P, Scaria A, Stepien S, Cheng AC, Edwards LJ, Robinson EJ, Sumpton C, Amin J, Liu B. Measuring oral COVID 19 antiviral effectiveness using linked Australian data: challenges and opportunities. Journal of Infection and Public Health 2026;19:103247. doi:10.1016/j.jiph.2026.103247
. [Full text]

Rice E, Cheng AC, Britton PN, Carr J, Clark JE, Crawford NW, Francis JR, Macartney KK, Marshall HS, Wood NJ, Blyth CC; PAEDS-FluCAN network. Influenza epidemiology, treatment and prevention in Australian children: trends from 6 years of PAEDS-FluCAN influenza surveillance (2019-2024). Vaccine 2026;82:128592. doi: 10.1016/j.vaccine.2026.128592 . [Full text]

McDonald E, Pittet LF, Bonten M, Byrne A, Campbell J, Croda J, Dalcolmo M, Davidson AJ, Dos Santos G, Gardiner K, Gwee A, Jardim B, Lacerda M, Lucas M, Lynn DJ, Manning L, Marshall H, Perrett KP, Prat-Aymerich C, Puga MA, Richmond P, Rodríguez-Baño J, Wadia U, Warris A, Wood N, Curtis N, Messina NL; BRACE Trial Consortium Group. Optimising COVID-19 episode identification using serology and PCR/rapid antigen testing: insights from the BRACE trial. BMC Infectious Diseases 2026. doi: 10.1186/s12879-026-13128-6 . [Full text]

Shetty AN, Mallard JH, Hennessy D, Wood N, Clothier HJ, Buttery JP; SAFESIG–GP Primary Health Network (PHN) Collaboration Group. Giant cell arteritis following COVID-19 vaccination: a consumer-stimulated analysis. Drug Safety 2026;49:705-715. doi: 10.1007/s40264-026-01650-0. [Full text]

Nguyen T, Jones B, Hickie M, Macartney K, Wood N, Deng L. Surveillance of adverse events following immunisation in Australia, 2023. Communicable Diseases Intelligence (2018) 2026;50. doi: 10.33321/cdi.2026.50.002. [Full text]

Craig AT, Lawford HL, Mokoia G, Tatui P, Nicolas M, Murphy A, Marquardt T, Nghiem SH, Stanciole AE, Lau CL. Comparison of an integrated versus stand-alone approach to post-validation surveillance for lymphatic filariasis in Niue: a micro-costing study, 2025. Journal of Global Health 2026;16:04157. doi: 10.7189/jogh.16.04157. [Full text]